Home › Pancreatic Cancer › New Hampshire
Pancreatic Cancer clinical trials in New Hampshire
4 studies for Pancreatic Cancer are looking for participants at sites in New Hampshire.
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
- Dartmouth Hitchcock Medical Center, Lebanon
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07409272Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
- Dartmouth Hitchcock Medical Center/Dartmouth Cancer Center, Lebanon
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT0695832824BRO681 : Alternating Gnp and mFOLFIRINOX for BR-PDAC
- Dartmouth-Hitchcock Medical Center, Lebanon
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07043270A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
- Ohio State University-Telemedicine, Concord
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06906562From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.